NCT02129049 Telephone-Based Educational Intervention in Improving Communication Between Patients With Stage 0-III Cancer and Their Children Status COMPLETED Phase NA
NCT02108444 Hepatitis B Virus Reactivation After Withdrawal of Prophylactic Antiviral Therapy in Lymphoma Patients Status COMPLETED Phase N/A
NCT02107443 Improving Communication in Older Cancer Patients and Their Caregivers Status COMPLETED Phase NA
NCT02106988 Concurrent Chemotherapy and Radiation Therapy for Newly Diagnosed Nasal NK Cell Lymphoma Status ACTIVE_NOT_RECRUITING Phase PHASE2
NCT02095951 Preemptive Ethanol Lock Therapy in Pediatric Bloodstream Infection Status COMPLETED Phase PHASE4
NCT02091063 ACY-1215 for Relapsed/Refractory Lymphoid Malignancies Status TERMINATED Phase PHASE1/PHASE2
NCT02082626 Study of Eribulin in Children With Cancer to Determine Safety Status TERMINATED Phase PHASE1
NCT02076451 Open-label Study of DS-8273a to Assess Its Safety and Tolerability, and Assess Its Pharmacokinetic and Pharmacodynamic Properties in Subjects With Advanced Solid Tumors or Lymphomas Status COMPLETED Phase PHASE1
NCT02072655 Impact of Socio-aesthetic Care in the Quality of Life of Patients Treated for Lymphoma During and After Hospitalization Status COMPLETED Phase NA
NCT02065154 Post Transplant Cyclophosphamide (Cytoxan) for GvHD Prophylaxis Status COMPLETED Phase PHASE2
NCT02062632 Doxepin Hydrochloride in Treating Esophageal Pain in Patients With Thoracic Cancer Receiving Radiation Therapy to the Thorax With or Without Chemotherapy Status TERMINATED Phase PHASE2
NCT02056548 Hepatitis B Virus Reactivation After Withdrawal of Preemptive Antiviral Therapy in Hematologic Malignancy Status UNKNOWN Phase N/A
NCT02054741 Geriatric Assessment Intervention for Reducing Toxicity in Older Patients With Advanced Cancer Status COMPLETED Phase NA
NCT02053545 Haplo-identical SCT for High Risk (HR) Hematologic Malignancies w/Post-Transplant In-Vivo T-cell Depletion Status WITHDRAWN Phase PHASE1/PHASE2
NCT02049580 Reduced Intensity Conditioning (RIC) Regimen and Post-transplant Cyclophosphamide in Haploidentical Bone Marrow Transplantation in in Patients With Poor Prognosis Lymphomas Status UNKNOWN Phase PHASE2
NCT02042950 A Phase II Study of Carfilzomib in the Treatment of Relapsed/Refractory Mantle Cell Lymphoma Status TERMINATED Phase PHASE2
NCT02038946 Study of Nivolumab in Subjects With Relapsed or Refractory Follicular Lymphoma (FL) (CheckMate 140) Status COMPLETED Phase PHASE2
NCT02014129 A Study of LY2835219 in Japanese Participants With Advanced Cancer Status COMPLETED Phase PHASE1
NCT02012465 Validation of Insulin Protocol for Glucocorticoid-induced Hyperglycemia in Diabetic Oncology Patients Status COMPLETED Phase EARLY_PHASE1